tradmap

CTKB Cytek Biosciences, Inc.

$4.70 +0.21%

Updated

Healthcare · Laboratory Analytical Instruments

Cytek Biosciences, Inc. (CTKB) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $611 million. Shares last traded at $4.70, 25.5% below their 52-week high. Over the past year the stock is up 19.1%. Net profit margin is -32.2%, below the peer median of -1.7%. Revenue grew 0.5% year over year.

Market Cap
$611M
Shares Out
130.0M
EPS (TTM)
$-0.01
P/E Ratio
P/S Ratio
2.96
P/B Ratio
1.90
Dividend / Share
Dividend Yield
52-Week High
$6.31
52-Week Low
$3.31
Volume
30,556
Avg Vol (3m)
92,257.746

Performance

1W
+1.95%
1M
+13.53%
3M
+8.80%
6M
+7.43%
YTD
-4.28%
1Y
+19.14%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
53.98
SMA (50)
$4.55
SMA (200)
$4.62
Price vs SMA50
+3.33%
Price vs SMA200
+1.83%
ATR (14)
$0.23

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$207M
Net Income
$-67M
Gross Margin
53.2%
Operating Margin
-21.6%
Net Margin
-32.2%
Return on Equity
-20.7%
Return on Assets
-14.9%
Current Ratio
4.48
Debt / Equity
0.39
Revenue Growth (YoY)
+0.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
FY 2023 $-0.09 2024-03-13
FY 2023 $0.02 2024-03-13
Q3 2022 $-0.01 2022-11-09
Q2 2022 $-0.02 2022-08-10
Q1 2022 $0.02 2022-05-12
FY 2023 $0.00 2024-03-13

Full earnings history →

Laboratory Analytical Instruments peers

CTKB vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/S vs peers
2.96 / 5.01 med
-41% discount
Net margin vs peers
-32.2% / -1.7% med
below median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.